SCHEMBL2369709

SCHEMBL2369709

OCc1cc(Cl)nc(Nc2nc3cccnc3s2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.52
RAB9A P51151 4/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
ITK Q08881 2/20 0.48
LCK P06239 1/20 0.48
AURKB Q96GD4 1/20 0.48
POLB P06746 1/20 0.47
TYK2 P29597 2/20 0.39
KDM4E B2RXH2 3/20 0.37
PDK1 Q15118 1/20 0.37
ATM Q13315 1/20 0.36
RECQL P46063 1/20 0.36
SSTR5 P35346 1/20 0.36
BUB1 O43683 1/20 0.36
MAPT P10636 3/20 0.35
PPARG P37231 1/20 0.35
NR2E3 Q9Y5X4 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
MAPK1 P28482 1/20 0.35
HCRTR1 O43613 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10285818 0.85 NPC1 (0.49) NPC1RAB9ASMN1; SMN2ITKLCK
SCHEMBL798710 0.80 LCK (0.45) NPC1RAB9ASMN1; SMN2ITKLCK
SCHEMBL2370127 0.80 NPC1 (0.44) NPC1RAB9ASMN1; SMN2ITKLCK
SCHEMBL2370061 0.80 NPC1 (0.47) NPC1RAB9ASMN1; SMN2ITKLCK
SCHEMBL2370507 0.79 ITK (0.66) NPC1RAB9ASMN1; SMN2ITKLCK
SCHEMBL2370517 0.79 ITK (0.66) NPC1RAB9ASMN1; SMN2ITKLCK
SCHEMBL2370005 0.74 RAB9A (0.51) NPC1RAB9ASMN1; SMN2POLBMAPT
SCHEMBL139226 0.72 ITK (0.64) NPC1RAB9ASMN1; SMN2ITKLCK
SCHEMBL140356 0.69 ITK (0.80) ITKLCKAURKBPOLB
SCHEMBL140357 0.69 ITK (0.80) ITKLCKAURKBPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011110575-A1 DERIVATIVES OF 2-[2-(BENZO- OR PYRIDO-) THIAZOLYLAMINO]-6-AMINOPYRIDINE, USEFUL IN THE TREATMENT OF RESPIRATORIC, ALLERGIC OR INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2011-09-15 WO disclosed